Where Ellomay Capital stands after its latest Filing
Revenue for the twelve months was $48m, up 10.6% on a year earlier, against a decline of 17.1% a quarter earlier. Free-cash-flow margin fell to -222.7% from -142.2% a year earlier. Operating margin widened to 43.1% from 10.8%. The diluted share count is up 3.0% on a year earlier, which dilutes existing holders. Against its peers on growth, profitability, cash generation and balance sheet, it grades B. It passes 5 of our 7 financial-health checks. Our book value value is $11.97 a share, against a share price of $20.40.